Roquette Pharma
Geneva, IL (US) · United States
Specialization: Plant-Based Excipients
Key Differentiator
Acquired IFF Pharma Solutions for ~$2.85B (completed May 2025) — now dominant in cellulose + mannitol excipients; opened $25M Pharmaceutical Innovation Centre near Philadelphia (Apr 2023)
Core Services
PEARLITOL (mannitol), LYCATAB (starch), KLEPTOSE (cyclodextrins), SG Caps (starch softgel capsules), excipients for ODT, parenteral, and inhalation
Capabilities
Market Intelligence
Roquette + IFF Pharma = major consolidation event; launched 3 new grades for moisture-sensitive APIs (Jan 2025)
Website
https://roquette.comSimilar Companies
Ashland (Pharma)
Wilmington, DE · Polymers & Specialty Ingredients
NYSE: ASH; broad polymer portfolio enabling modified-release and ODT formulations; critical role in amorphous solid dispersion technology for poorly soluble drugs
Avantor / J.T. Baker
Radnor, PA · High-Purity Chemicals & Excipients
NYSE: AVTR; $7.3B revenue; critical supplier of high-purity process chemicals to biopharma; opened advanced Dublin distribution center (Nov 2022)
Colorcon
Harleysville, PA · Film Coatings & Colorants
World leader in film coating systems; signed $740M 10-year deal with Lotte Fine Chemical for pharma cellulose (Oct 2024); global supply + application labs network
DFE Pharma
Toronto region, ON · Lactose & Inhalation Excipients
World leader in lactose-based excipients; Canadian distribution serving growing domestic pharma manufacturing sector
Need help finding the right outsourcing partner?
Try AI NavigatorCompany information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.